Reelin influences the expression and function of dopamine D2 and serotonin 5-HT2A receptors: A comparative study

Neuroscience

Volumn 290, Issue , 2015, Pages 165-174

  Varela, M J ^a,c   Lage, S ^a   Caruncho, H J ^b   Cadavid, M I ^a   Loza, M I ^a   Brea, J ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Frontal cortex; GPCRs; Heterozygous reeler mice; Reelin; Schizophrenia; Striatum

Indexed keywords

DOPAMINE 2 RECEPTOR; REELIN; SEROTONIN 2A RECEPTOR; DRD2 PROTEIN, MOUSE; GUANOSINE 5'-O-(GAMMA-AMIDOTRIPHOSPHATE); GUANOSINE TRIPHOSPHATE; LYSERGIDE; NERVE CELL ADHESION MOLECULE; NERVE PROTEIN; REELIN PROTEIN; SCLEROPROTEIN; SERINE PROTEINASE; SULFUR; TRITIUM;

ADULT; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; FRONTAL CORTEX; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; STRAIN DIFFERENCE; ANALOGS AND DERIVATIVES; ANIMAL; FRONTAL LOBE; GENETICS; METABOLISM; MOUSE MUTANT; RADIOASSAY;

ANIMALS; CELL ADHESION MOLECULES, NEURONAL; CORPUS STRIATUM; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FRONTAL LOBE; GUANOSINE TRIPHOSPHATE; LYSERGIC ACID DIETHYLAMIDE; MALE; MICE; MICE, NEUROLOGIC MUTANTS; NERVE TISSUE PROTEINS; RADIOLIGAND ASSAY; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, DOPAMINE D2; SERINE ENDOPEPTIDASES; SULFUR RADIOISOTOPES; TRITIUM;

EID: 84922370171     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2015.01.031     Document Type: Article

References (55)

1. Abi-Dargham A. Do we still believe in the dopamine hypothesis? New data bring new evidence. Int J Neuropsychopharmacol 2004, 7(Suppl. 1):S1-S5.
2. Albizu L., Holloway T., González-Maeso J., Sealfon S.C. Neuropharmacology 2011, 61:770-777.
3. Andersen T.E., Finsen B., Goffinet A.M., Issinger O.G., Boldyreff B. A reeler mutant mouse with a new, spontaneous mutation in the reeler gene. Brain Res Mol Brain Res 2002, 105:153-156.
4. Arora R.C., Meltzer H.Y. Serotonin2 (5-HT2) receptor binding in the frontal cortex of schizophrenic patients. J Neural Transm Gen Sect 1991, 85:19-29.
5. Ballmaier M., Zoli M., Leo G., Agnati L.F., Spano P. Eur J Neurosci 2002, 2002(15):1197-1205.
6. Bar I., Lambert de Rouvroit C., Royaux I., Krizman D.B., Dernoncourt C., Ruelle D., et al. A YAC contig containing the reeler locus with preliminary characterization of candidate gene fragments. Genomics 1995, 26:543-549.
7. Bennett J.P., Enna S.J., Bylund D.B., Gillin J.C., Wyatt R.J., Snyder S.H. Neurotransmitter receptors in frontal cortex of schizophrenics. Arch Gen Psychiatry 1979, 36:927-934.
8. 2A)receptorsassembleintofunctionally interactingheteromers. Biochem Biophys Res Commun 2010, 401:605-610.
9. Borroto-Escuela D.O., Romero-Fernandez W., Narvaez M., Oflijan J., Agnati L.F., Fuxe K. Biochem Biophys Res Commun 2014, 443:278-284.
10. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
11. Caruncho H.J., Dopeso-Reyes I.G., Loza M.I., Rodríguez M.A. A GABA, reelin, and the neurodevelopmental hypothesis of schizophrenia. Crit Rev Neurobiol 2004, 16:25-32.
12. Costa E., Davis J., Grayson D.R., Guidotti A., Pappas G.D., Pesold C. Dendritic spine hypoplasticity and downregulation of reelin and GABAergic tone in schizophrenia vulnerability. Neurobiol Dis 2001, 8:723-742.
13. D'Arcangelo G., Miao G.G., Chen S.C., Soares H.D., Morgan J.I., Curran T. A protein related to extracellular matrix proteins deleted in the mouse mutant reeler. Nature 1995, 374:719-723.
14. de Bartolomeis A., Buonaguro E.F., Iasevoli F. Serotonin-glutamate and serotonin-dopamine reciprocal interactions as putative molecular targets for novel antipsychotic treatments: from receptor heterodimers to postsynaptic scaffolding and effector proteins. Psychopharmacology 2013, 225:1-19.
15. Dean B. The cortical serotonin2A receptor and the pathology of schizophrenia: a likely accomplice. J Neurochem 2003, 85:1-13.
16. Dean B., Hayes W. Decreased frontal cortical serotonin2A receptors in schizophrenia. Schizophr Res 1996, 21:133-139.
17. Dean B., Hayes W., Opeskin K., Naylor L., Pavey G., Hill C., et al. Serotonin2 receptors and the serotonin transporter in the schizophrenic brain. Behav Brain Res 1996, 73:169-175.
18. Dong E., Caruncho H., Liu W.S., Smalheiser N.R., Grayson D.R., Costa E., et al. A reelin-integrin receptor interaction regulates Arc mRNA translation in synaptoneurosomes. Proc Natl Acad Sci USA 2003, 100:5479-5484.
19. Fatemi S.H., Earle J.A., McMenomy T. Reduction in reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression. Mol Psychiatry 2000, 5:654-663.
20. Förster E., Bock H.H., Herz J., Chai X., Frotscher M., Zhao S. Emerging topics in reelin function. Eur J Neurosci 2010, 31:1511-1518.
21. Guidotti A., Auta J., Davis J.M., DiGiorgi-Gerevini V., Dwivedi Y., Grayson D.R., et al. Decrease in reelin and glutamic acid decarboxylase 67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch Gen Psychiatry 2000, 57:1061-1069.
22. Guillin O., Abi-Dargham A., Laruelle M. Neurobiology of dopamine in schizophrenia. Int Rev Neurobiol 2007, 78:1-39.
23. Hernandez I., Sokolov B.P. Abnormalities in 5-HT2A receptor mRNA expression in frontal cortex of chronic elderly schizophrenics with varying histories of neuroleptic treatment. J Neurosci Res 2000, 59:218-225.
24. Hurlemann R., Boy C., Meyer P.T., Scherk H., Wagner M., Herzog H., et al. Decreased prefrontal 5-HT2A receptor binding in subjects at enhanced risk for schizophrenia. Anat Embryol (Berl) 2005, 210:519-523.
25. Impagnatiello F., Guidotti A.R., Pesold C., Dwivedi Y., Caruncho H., Pisu M.G., et al. A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proc Natl Acad Sci USA 1998, 95:15718-15723.
26. Jia P., Sun J., Guo A.Y., Zhao Z. SZGR: a comprehensive schizophrenia gene resource. Mol Psychiatry 2010, 15:453-462.
27. Kim S., Webster M.J. The Stanley Neuropathology Consortium Integrative Database: a novel, web-based tool for exploring neuropathological markers in psychiatric disorders and the biological processes associated with abnormalities of those markers. Neuropsychopharmacology 2010, 35:473-482.
28. Knable M.B., Barci B.M., Webster M.J., Meador-Woodruff J., Torrey E.F. Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium. Mol Psychiatry 2004, 9:609-620.
29. Laruelle M., Abi-Dargham A., Casanova M.F., Toti R., Weinberger D.R., Kleinman J.E. Selective abnormalities of prefrontal serotonergic receptors in schizophrenia. A postmortem study. Arch Gen Psychiatry 1993, 50:810-818.
30. Lee T., Seeman P. Elevation of brain neuroleptic/dopamine receptors in schizophrenia. Am J Psychiatry 1980, 137:191-197.
31. Liu W.S., Pesold C., Rodriguez M.A., Carboni G., Auta J., Lacor P., et al. Down-Regulation of dendritic spine and glutamic acid decarboxylase 67 expressions in the reelin haploin sufficient heterozygous reeler mouse. Proc Natl Acad Sci USA 2001, 98:3477-3482.
32. Lukasiewicz S., Polit A., Kedracka-Krok S., Wedzony K., Maćkowiak M., Dziedzicka-Wasylewska M. Hetero-dimerization of serotonin 5-HT(2A) and dopamine D(2) receptors. Biochim Biophys Acta 2010, 1803:1347-1358.
33. Lussier A.L., Romay-Tallon R., Kalynchuk L.E., Caruncho H.J. Reelin as a putative vulnerability factor for depression: examining the depressogenic effects of repeated corticosterone in heterozygous reeler mice. Neuropharmacology 2011, 60:1064-1074.
34. Maloku E., Covelo I.R., Hanbauer I., Guidotti A., Kadriu B., Hu Q., et al. Lower number of cerebellar Purkinje neurons in psychosis is associated with reduced reelin expression. Proc Natl Acad Sci USA 2010, 107:4407-4411.
35. Matsumoto I., Inoue Y., Iwazaki T., Pavey G., Dean B. 5-HT2A and muscarinic receptors in schizophrenia: a postmortem study. Neurosci Lett 2005, 379:164-168.
36. Matsuzaki H., Minabe Y., Nakamura K., Suzuki K., Iwata Y., Sekine Y., et al. Disruption of reelin signaling attenuates methamphetamine-induced hyperlocomotion. Eur J Neurosci 2007, 25:3376-3384.
37. Mita T., Hanada S., Nishino N., Kuno T., Nakai H., Yamadori T., et al. Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics. Biol Psychiatry 1986, 21:1407-1414.
38. Ognibene E., Adriani W., Caprioli A., Ghirardi O., Ali S.F., Aloe L., et al. The effect of early maternal separation on brain derived neurotrophic factor and monoamine levels in adult heterozygous reeler mice. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:1269-1276.
39. Panagopoulos N.T., Matsokis N.A., Valcana T. Cerebellar and striatal dopamine receptors: effects of reeler and weaver murine mutations. J Neurosci Res 1993, 35:499-506.
40. Pesold C., Impagnatiello F., Pisu M.G., Uzunov D.P., Costa E., Guidotti A., et al. Reelin is preferentially expressed in neurons synthesizing gamma-aminobutyric acid in cortex and hippocampus of adult rats. Proc Natl Acad Sci USA 1998, 95:3221-3226.
41. Pralong D., Tomaskovic-Crook E., Opeskin K., Copolov D., Dean B. Serotonin(2A) receptors are reduced in the planum temporale from subjects with schizophrenia. Schizophr Res 2000, 44:35-45.
42. Reynolds G.P., Rossor M.N., Iversen L.L. Preliminary studies of human cortical 5-HT2 receptors and their involvement in schizophrenia and neuroleptic drug action. J Neural Transm Suppl 1983, 18:273-277.
43. Seeman P., Bzowej N.H., Guan H.C., Bergeron C., Reynolds G.P., Bird E.D., et al. Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases. Neuropsychopharmacology 1987, 1:5-15.
44. Soares J.C., Innis R.B. Neurochemical brain imaging investigations of schizophrenia. Biol Psychiatry 1999, 46:600-615.
45. Strasser V., Fasching D., Hauser C., Mayer H., Bock H.H., Hiesberger T., et al. Receptor clustering is involved in reelin signaling. Mol Cell Biol 2004, 24:1378-1386.
46. Tallerico T., Novak G., Liu I.S.C., Ulpian C., Seeman P. Schizophrenia: elevated mRNA for dopamine D2Longer receptors in frontal cortex. Mol Brain Res 2001, 87:160-165.
47. Tandon R., Keshavan M.S., Nasrallah H.A. Schizophrenia, "Just the Facts" what we know in 2008. 2. Epidemiology and etiology. Schizophr Res 2008, 102:1-18.
48. Tueting P., Costa E., Dwivedi Y., Guidotti A., Impagnatiello F., Manev R., et al. The phenotypic characteristics of heterozygous reeler mouse. NeuroReport 1999, 10:1329-1334.
49. Tueting P., Doueiri M.S., Guidotti A., Davis J.M., Costa E. Reelin down-regulation in mice and psychosis endophenotypes. Neurosci Biobehav Rev 2006, 30:1065-1077.
50. Tueting P., Pinna G., Costa E. Homozygous and heterozygous reeler mouse mutants. Reelin glycoprotein: structure, biology and roles in health and disease 2008, 291-309. Springer, Minneapolis. S.H. Fatemi (Ed.).
51. Ujike H., Akiyama K., Kuroda S. [3H]YM-09151-2 (nemonapride), a potent radioligand for both sigma 1 and sigma 2 receptor subtypes. NeuroReport 1996, 1996(7):1057-1061.
52. Urigüen L., García-Fuster M.J., Callado L.F., Morentín B., La Harpe R., Casadó V., et al. Immunodensity and mRNA expression of A2A adenosine, D2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: effect of antipsychotic treatment. Psychopharmacology 2009, 206:313-324.
53. van den Buuse M., Halley P., Hill R., Labots M., Martin S. Altered N-methyl-d-aspartate receptor function in reelin heterozygous mice: male-female differences and comparison with dopaminergic activity. Prog Neuropsychopharmacol Biol Psychiatry 2012, 37:237-246.
54. Wedenoja J., Loukola A., Tuulio-Henriksson A., Paunio T., Ekelund J., Silander K., et al. Replication of linkage on chromosome 7q22 and association of the regional Reelin gene with working memory in schizophrenia families. Mol Psychiatry 2008, 13:673-684.
55. Whitaker P.M., Crow T.J., Ferrier I.N. Tritiated LSD binding in frontal cortex in schizophrenia. Arch Gen Psychiatry 1981, 38:278-280.